SCNI
Scinai Immunotherapeutics
SCNI
SCNI
14 hedge funds and large institutions have $789K invested in Scinai Immunotherapeutics in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$118K | |
| 2 | +$116K | |
| 3 | +$74K | |
| 4 |
TPWA
TRUE Private Wealth Advisors
Salem,
Oregon
|
+$44.6K |
| 5 |
State Street
Boston,
Massachusetts
|
+$13.6K |
Top Sellers
| 1 | -$78K | |
| 2 | -$49K | |
| 3 | -$40K | |
| 4 |
Morgan Stanley
New York
|
-$4.49K |
| 5 |
GRP
Global Retirement Partners
San Rafael,
California
|
-$1K |